Bacterin International reports positive clinical results for OsteoSponge product Bacterin International announces that the first clinical results using the OsteoSponge SC product for regeneration of subchondral bone in complex lesions of the talus involving advanced subchondral bone damage have been published in the peer reviewed journal, Foot & Ankle Specialist. Each of the seven patients reported a clinically significant reduction in pain and improvement in activity at six months post-operation relative to their preoperative baseline scores. MRI confirmed graft incorporation and restoration of an intact subchondral plate.
News For BONE From The Last 14 Days
Check below for free stories on BONE the last two weeks.
Subscribe for More Information